Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KMB vs MRNA✓SelectedUSD · MRNAKMB vs MRNA performance historyLatest closeAs of-1.86%11/19
Stock and ETF performance explorer

KMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+22.9%
MRNA return
+806.0%
Excess return
-783.1%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.9%+1.3%-3.1%-1.9%
7D-1.8%-13.8%+12.0%-1.5%
30D-2.8%-17.7%+14.8%-2.6%
3M-3.1%+14.3%-17.4%-3.6%
6M+11.9%+336.0%-324.1%+6.3%
YTD+8.3%+575.9%-567.6%+1.3%
1Y+8.1%+724.4%-716.3%+0.3%
3Y-1.7%+160.8%-162.5%-6.9%
5Y-4.8%-24.4%+19.6%-7.7%
All+22.9%+806.0%-783.1%-1.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling